Acticor Biotech (France) Today
| ALACT Stock | EUR 3.89 0.07 1.83% |
Performance0 of 100
| Odds Of DistressLess than 23
|
Acticor Biotech is selling at 3.89 as of the 24th of April 2024; that is 1.83% increase since the beginning of the trading day. The stock's last reported lowest price was 3.78. Acticor Biotech has about a 23 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Acticor Biotech SAS are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of March 2024 and ending today, the 24th of April 2024. Click here to learn more.
Acticor Biotech SAS, a clinical stage biopharmaceutical company, develops drugs for the treatment of acute phase of thrombotic diseases. The company was founded in 2013 and is headquartered in Paris, France. ACTIPLAY is traded on Paris Stock Exchange in France. The company has 10.52 M outstanding shares. More on Acticor Biotech SAS
Moving against Acticor Stock
| 0.64 | AIR | Airbus Group SE Earnings Call Tomorrow | PairCorr |
| 0.63 | BNP | BNP Paribas SA Earnings Call Tomorrow | PairCorr |
| 0.61 | ACA | Credit Agricole SA | PairCorr |
| 0.61 | GLE | Societe Generale | PairCorr |
| 0.53 | RNO | Renault SA | PairCorr |
| 0.43 | CS | AXA SA | PairCorr |
Acticor Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Acticor Biotech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Acticor Biotech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | Julien Parrou |
| Thematic Idea | IT (View all Themes) |
| Business Concentration | IT, Communication Services, Media, Advertising Agencies, Communication Services, Computing (View all Sectors) |
Acticor Biotech SAS (ALACT) is traded on Euronext Paris in France and employs 25 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 95.69 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Acticor Biotech's market, we take the total number of its shares issued and multiply it by Acticor Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Acticor Biotech SAS operates under Media sector and is part of Communication Services industry. The entity has 10.52 M outstanding shares.
Acticor Biotech SAS has accumulated about 571.18 K in cash with (13.75 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.17.
Check Acticor Biotech Probability Of Bankruptcy
Acticor Stock Price Odds Analysis
In regard to a normal probability distribution, the odds of Acticor Biotech jumping above the current price in 90 days from now is about 59.3%. The Acticor Biotech SAS probability density function shows the probability of Acticor Biotech stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Acticor Biotech SAS has a beta of -0.7187. This suggests as returns on the benchmark increase, returns on holding Acticor Biotech are expected to decrease at a much lower rate. During a bear market, however, Acticor Biotech SAS is likely to outperform the market. Additionally, acticor Biotech SAS has an alpha of 0.6965, implying that it can generate a 0.7 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Acticor Biotech to move above the current price in 90 days from now is about 59.3 (This Acticor Biotech SAS probability density function shows the probability of Acticor Stock to fall within a particular range of prices over 90 days) .
Acticor Biotech SAS Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Acticor Biotech market risk premium is the additional return an investor will receive from holding Acticor Biotech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Acticor Biotech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Acticor Biotech's alpha and beta are two of the key measurements used to evaluate Acticor Biotech's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 4.19 | |||
| Semi Deviation | 5.76 | |||
| Standard Deviation | 7.11 | |||
| Variance | 50.5 |
Acticor Stock Against Markets
Picking the right benchmark for Acticor Biotech stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Acticor Biotech stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Acticor Biotech is critical whether you are bullish or bearish towards Acticor Biotech SAS at a given time. Please also check how Acticor Biotech's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Acticor Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
| All Next | Launch Module |
Acticor Biotech Corporate Directors
Acticor Biotech corporate directors refer to members of an Acticor Biotech board of directors. The board of directors generally takes responsibility for the Acticor Biotech's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Acticor Biotech's board members must vote for the resolution. The Acticor Biotech board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Patrice Coffe | Administrative and Financial Director, Member of the Board | Profile | |
| Gerard Parrou | Member of the Board of Directors | Profile | |
| Jeremy Ducournau | Director of B2B Solutions Business Development | Profile | |
| Laurent Crouzillac | Director Representative of Idinvest Partners | Profile |
How to buy Acticor Stock?
Before investing in Acticor Biotech, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Acticor Biotech. To buy Acticor Biotech stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Acticor Biotech. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Acticor Biotech stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Acticor Biotech SAS stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Acticor Biotech SAS stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Acticor Biotech SAS, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Acticor Biotech SAS?
The danger of trading Acticor Biotech SAS is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Acticor Biotech is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Acticor Biotech. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Acticor Biotech SAS is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Acticor Biotech SAS. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Complementary Tools for Acticor Stock analysis
When running Acticor Biotech's price analysis, check to measure Acticor Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acticor Biotech is operating at the current time. Most of Acticor Biotech's value examination focuses on studying past and present price action to predict the probability of Acticor Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acticor Biotech's price. Additionally, you may evaluate how the addition of Acticor Biotech to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |